Skip to main content

Advertisement

Fig. 10 | Biomarker Research

Fig. 10

From: Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers

Fig. 10

Immunostaining of caspase-6 and caspase-6 in human ovarian in high grade serous carcinoma. Caspase-3 is absent in ovarian carcinoma (a) while caspase-6 is heterogeneously expressed in the cytoplasm and in the nucleus in ovarian carcinoma (b). Down regulation of caspase-3 in ovarian carcinoma (a) is associated to the upregulation and cytoplasmic localization of caspase-6 (b)

Back to article page